Certificate under SEBI (Depositories and Participants) Regulations, 2018

October 9, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 With reference to the captioned subject, please find enclosed herewith a copy of the certificate received from KFin Technologies Limited, the Registrar to an Issue and Share Transfer Agent of the Company for the quarter ended on September 30, 2026. Request you to kindly take the above on record. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a R:/KFIN/R74(5) Date: 09.10.2026 THE COMPANY SECRETARY MANKIND PHARMA LIMITED 236, OKHLA INDUSTRIAL ESTATE PHASE – 3, NEW DELHI, 110020 Dear Sir(s), Sub: Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories & Participants) Regulations 2018 ('Regulations') for the quarter ended September 30, 2026. With reference to the above captioned Regulations, we hereby confirm that during the period from July 01, 2026, to September 30, 2026, we have not received any requests for dematerialisation/rematerialisation of shares of Mankind Pharma Limited, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018. Thanking you, Yours faithfully, KFIN TECHNOLOGIES LIMITED Dnyanesh Gharote Vice President